Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer (Q37117151)
Jump to navigation
Jump to search
scientific article published on 27 October 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer |
scientific article published on 27 October 2008 |
Statements
1 reference
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer (English)
1 reference
Zeba Aziz
1 reference
Zanete Zvirbule
1 reference
Jose Bines
1 reference
Michael C Arbushites
1 reference
Stephanie F Guerrera
1 reference
Maria Koehler
1 reference
Steven H Stein
1 reference
Lisa S Williams
1 reference
Richard S Finn
1 reference
Michael F Press
1 reference
27 October 2008
1 reference
1 reference
5544-5552
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference